Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?

West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

$SPX : 6,861.89 (-0.28%)
MS : 173.15 (-0.70%)
WST : 242.21 (-0.66%)
MDEV : 20.60 (-0.29%)
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call

5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call

WST : 242.21 (-0.66%)
West Announces Quarterly Dividend and Share Repurchase Program

EXTON, Pa. , Feb. 17, 2026 /PRNewswire/ -- On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable...

WST : 242.21 (-0.66%)
West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars

West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars

WST : 242.21 (-0.66%)
West Pharmaceutical: Q4 Earnings Snapshot

West Pharmaceutical: Q4 Earnings Snapshot

WST : 242.21 (-0.66%)
West Reports Fourth-Quarter and Full-Year 2025 Results

– Strong 4Q results, driven by double-digit organic revenue growth in HVP Components –

WST : 242.21 (-0.66%)
West Pharmaceutical Services Earnings: What To Look For From WST

West Pharmaceutical Services Earnings: What To Look For From WST

WST : 242.21 (-0.66%)
3 Cash-Producing Stocks with Open Questions

3 Cash-Producing Stocks with Open Questions

SNA : 383.87 (-0.13%)
WST : 242.21 (-0.66%)
VPG : 44.88 (-4.33%)
West to Host Fourth-Quarter and Full-Year 2025 Conference Call

EXTON, Pa. , Jan. 29, 2026 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that...

WST : 242.21 (-0.66%)
Stocks Finish Mostly Higher Despite a Plunge in Intel

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.34%. March E-mini...

GOOGL : 307.67 (+1.59%)
AAPL : 259.40 (-0.45%)
B : 48.85 (+0.62%)
AVGO : 333.55 (-0.13%)
HL : 23.62 (+3.64%)
SNDK : 639.09 (+2.90%)
CDE : 24.62 (+2.33%)
ADI : 347.01 (+0.50%)
TXN : 217.96 (-0.04%)
$IUXX : 24,797.34 (-0.41%)
ZNH26 : 112-315 (+0.01%)
MSFT : 395.83 (-0.66%)

Barchart Exclusives

Down 24% in 2026, Where Is Palantir Stock Headed Next and Should You Buy PLTR Here?
Palantir stock has been in a freefall this year amid a broader software rout, but Mizuho believes PLTR shares will recover sharply as the year unfolds. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar